Loading company…
myBiometry develops technology for asthma monitoring and management.
myBiometry provides a sensor that measures airway inflammation using fractional exhaled nitric oxide (FeNO), alongside an app for monitoring asthma risks and symptoms. Its tools are intended for patients, caregivers, and healthcare providers. Founded in 2013 by Bryan Nolan, the company is based in Lowell, US. Dexcom Ventures led its USD 4.98 million seed round in August 2024, with Caresource Management Group and Elevate Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in